Updates: $7B CMS Research, Measurement, Assessment, Design, & Analysis (RMADA) 2 IDIQ

Updated September 10, 2018

“Solicitation Number: 75FCMC19R0003
Notice Type: Presolicitation
The Centers for Medicare and Medicaid Services (CMS) intends to award an Indefinite Delivery Indefinite Quantity (IDIQ) contracts to provide CMS with a wide range of analytic support and technical assistance activities that support models and demonstration programs created or derived under the auspices of the Patient Protection & Affordable Care Act (ACA), the Medicare Access and CHIP Reauthorization Act (MACRA), other non-ACA statutes, and future health reform legislation. The demands of new reforms created under ACA have redefined the way CMS approaches and conducts research activities, Model Testing, and demonstrations affecting Medicare, Medicaid, CHIP, and…” Read the full notice here.

Update: While little additional detail was provided beyond what was already known, CMS did post a Presolicitation notice yesterday afternoon. It is coming!


Posted August 8, 2018

“Under this Research, Measurement, Assessment, Design, and Analysis Delivery Indefinite Quantity 2.0 (IDIQ) umbrella contract, the Centers for Medicare & Medicaid Services (CMS) shall award task orders (TOs) for a wide range of analytic support and technical assistance activities that support models and demonstration programs created or derived under the auspices of the Patient Protection & Affordable Care Act (ACA), the Medicare Access and CHIP Reauthorization Act (MACRA), other non-ACA statutes, and future health reform legislation. The demands of new reforms created under ACA have redefined the way CMS approaches and conducts research activities, Model Testing, and demonstrations affecting Medicare, Medicaid, CHIP, and uninsured populations. The role of state and private sector payers is also being redefined, as many of the new models include multiple payers working in collaboration with CMS to reform the care delivery system. Note: when the term model/demonstration is used throughout this work statement, CMS is also referring to other Innovative State based programs. The RMADA 2.0 IDIQ contract shall provide CMS with a robust tool to meet these needs and opportunities. The Contractor shall work with CMS on matters including but not limited to:
• Supporting all aspects of model design and operations (with the exception of information technology);
• Conducting program, data and environmental analyses;
• Assisting with application development and review;
• Monitoring model site implementations;
• Designing and carrying out surveys and other primary data collection activities;
• Obtaining and analyzing secondary data sources including data regarding Medicare, Medicaid, and the Children’s Health Insurance Program (CHIP) and data from private payer sources needed to support model design, operations and evaluations;
• Reporting on formative and summative analyses;
• Providing rapid cycle evaluation feedback to CMS and/or model participants,
• Implementing learning systems to support accelerated learning and improvement and dissemination of promising practices;
• Creating summative reports of annual and final program findings.
• Assist in the development of program templates, tools, toolkits, and driver diagrams;
• Support stakeholder engagement and training;
• Provide data analysis/ integration support;
• Assist in the development of program specific technical/policy resource guides and informational/ educational/ briefing materials; and
• Provide grant proposal reviews and summarization reports…” Read the full draft SOW here.

G2X TAKE: While quick to point out that it is NOT an IT contract, the draft SOW for the next generation of this $7B Multiple award IDIQ scheduled to expire next July, is certain to draw attention from a wide range of firms looking to partner on this important contract to provide analytic support and technical assistance to CMS for models and demonstration programs.

Included here is a link to the SOW and related Q&A from the original 2013 IDIQ solicitations documents. While much has changed at CMS in the past 5 years, expect CMS to leverage lessons learned from the original solicitation.

The 15 Prime awardees for the current RMADA IDIQ include:

  • Abt Associates
  • Acumen
  • American Institutes for Research
  • Arbor Research Collaborative for Health
  • Booz Allen Hamilton
  • Deloitte
  • IMPAQ International
  • Mathematica Policy Research
  • NORC at the University of Chicago
  • RAND Corporation
  • Regents of The University of Colorado
  • RTI International
  • Social & Scientific Systems Inc.
  • The Lewin Group (Part of Optum/United Health Care)
  • Truven Health Analytics (now IBM)

G2X will provide more information here related to this opportunity in the coming weeks and as it is made available.

Tags:

Tagged: ,

This topic contains 5 replies, has 3 voices, and was last updated by  Anonymous 1 month, 3 weeks ago.

  • Author
    Posts
  • #48001
     Abigail Smith
    • G2Xchange Health Online Community Manager
    • G2Xchange Health

    Replies viewable by members only

  • #48025

    Replies viewable by members only

    • #48028
       Jason Cullum
      • CMS Account SME
      • IBM

      Replies viewable by members only

      • #48029

        Replies viewable by members only

        • #48046

          Replies viewable by members only

  • #48999

    Replies viewable by members only

You must be logged in to reply to this topic.

CONTACT US

Questions?. Send us an email and we'll get back to you, asap.

Sending

©2018 G2Xchange all rights reserved | Community and Member Guidelines | Privacy Policy | About G2Xchange Health

Log in with your credentials

Forgot your details?